back to homepage

Mega-menu

New Drug Application Under FDA Review for Potential Combination CF Treatment 0

In November, Vertex Pharmaceuticals Inc. submitted a new drug application to the U.S. Food and Drug Administration (FDA) for approval of the combination of ivacaftor (Kalydeco™) and lumacaftor in people

Read More